Improving access to plant-based medicines for human health
Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health
This study is all about finding better ways to help plants produce natural compounds that are good for your health, so we can make more effective medicines from them for people who need new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11041049 on NIH RePORTER |
What this research studies
This research focuses on enhancing the production of natural compounds from plants that are important for human health. By using advanced techniques in genomics and metabolic engineering, the project aims to identify and optimize the pathways that plants use to create these beneficial molecules. The goal is to make these compounds more accessible for pharmaceutical use, which could lead to new treatments for various diseases. Patients may benefit from improved availability of effective plant-derived medications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new or improved plant-derived medications for conditions such as cancer or inflammation.
Not a fit: Patients who do not have conditions that can be treated with plant-derived compounds may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased availability of plant-based pharmaceuticals that treat a variety of health conditions.
How similar studies have performed: While there have been some successful applications of metabolic engineering in microbial systems, the approach of using next-generation omics technologies for plant natural products is still relatively novel.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Buell, Carol Robin — University of Georgia
- Study coordinator: Buell, Carol Robin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.